Home › Infertility › NCT07148999

An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for Provera

An Advanced Decision Support Tool for Personalized Medicine for IVF Using Modeling and Optimization for PPOS

Who can join

Ages 20 to 50 · Women · Healthy volunteers welcome

Inclusion Criteria:

* infertile women

Exclusion Criteria:

All female patients who will not undergo IVF or whose cycles will be converted to IUI. Male patients will not be enrolled in this study. No donor cycles.

About the study

A clinical trial will determine the effectiveness of using the Opt-IVF decision support tool for each patient's personalized and optimal drug dosage profile in the United States.

What is being tested

• Opt-IVF (combination product)
• Control (other)

Sponsor: Urmila DIwekar · Participants: 200 · Started: Sep 23, 2025

Contact the study team

• Urmila Diwekar, Ph.D. · Phone: 6308863047
• Sanjay Joag, M.D., Ph.D. · Phone: 6305014451

Official record on ClinicalTrials.gov — NCT07148999

Locations in the U.S.

Conditions

• Infertility

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.